Business, Policy & Funding Breaking news on Genetics & Genomics business, policy & funding. Could Mix It Up The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says. Offer to Come Back The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back. Molecular Assemblies Wins $256K NIH Phase I SBIR Grant to Develop Enzymatic DNA Synthesis The San Diego-based firm said the funding will help it develop three key steps in its chemistry: incorporation of nucleotides, deblocking, and cleanup. Vibrent Health, VCU Partner to Offer Twin Research Platform Vibrent has developed a digital research platform allowing individual investigators and other twin registries to collaborate on longitudinal studies. Castle Biosciences Acquires Cernostics for up to $80M Cernostics specializes in spatial biology and artificial intelligence-driven image analysis of tissue biopsies. Oct 18, 2021 Armonica Technologies Closes $2M Series B Financing Round Oct 18, 2021 Top Five Articles on GenomeWeb Last Week: SARS-CoV-2 PCR Tests; California Cancer Testing Law; More Oct 15, 2021 In Brief This Week: The Jackson Laboratory, CareDx, Merck Global Health Innovation Fund, and More Oct 15, 2021 People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More Oct 15, 2021 New Products Posted to GenomeWeb: NanoString, Sophia Genetics, EliTech, Lybe Scientific, More Oct 14, 2021 UPDATE: FDA Classifies Abbott SARS-CoV-2 Molecular Test Recall as Class I Due to False Positives Oct 14, 2021 Computomics Sells Minority Stakes to BASF Venture Capital, Amathaon Capital Oct 14, 2021 Genialis Expands Partnership With Slovenia's BioLab Oct 14, 2021 Caris Life Sciences, Ono Pharmaceutical Ink Cancer Drug Development Collaboration Oct 14, 2021 OpGen Enters $15M Registered Direct Offering Agreement Oct 14, 2021 Lucid Diagnostics Prices $70M IPO, Starts Trading on Nasdaq Oct 14, 2021 Biopix-T Gets CE Mark for Point-of-Care Platform, Molecular SARS-CoV-2 Test Oct 13, 2021 MDxHealth Files for IPO of American Depositary Shares Oct 13, 2021 C2i Genomics, NuProbe Global Enter Strategic Alliance for AI-Based Cancer Detection, Monitoring Oct 13, 2021 Mayo Clinic, Personalis Ink Comprehensive Genomics Research Collaboration Oct 13, 2021 California Bill Prohibiting Prior Authorizations for Cancer Biomarker Testing Becomes Law Oct 13, 2021 MiRxes to Expand miRNA Assay Technology to Multiple Cancer Types, Other Disease Areas Premium Oct 13, 2021 FDA Grants EUAs for Cleveland Clinic COVID-19 PCR Test, Quest Diagnostics Sample Self-Collection Kit Oct 13, 2021 GeneDx, Krystal Biotech Partner to Offer Free Genetic Testing for Rare Skin Disease Oct 12, 2021 Inscripta Licenses MAD7 CRISPR Nuclease to Hunterian Medicine Load More Breaking News Exome Sequencing of UK Biobank Participants Highlights Natural Variation, Gene Function Cystic Fibrosis Sinus Infections Involve Microbes With Shifting Evolution Patterns Molecular Assemblies Wins $256K NIH Phase I SBIR Grant to Develop Enzymatic DNA Synthesis Vibrent Health, VCU Partner to Offer Twin Research Platform Castle Biosciences Acquires Cernostics for up to $80M Princess Margaret Cancer Centre, Inivata Partner on Clinical Liquid Biopsy Studies The Scan Could Mix It Up The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says. Closest to the Dog New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs. Offer to Come Back The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back. PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.